Heart drug may limit scarring after attack
NCT ID NCT07325955
First seen Jan 10, 2026 · Last updated May 13, 2026 · Updated 12 times
Summary
This study looked at whether taking trimetazidine long-term can reduce the amount of scarring in the heart after a heart attack. Researchers followed 194 people who had a severe type of heart attack (STEMI) and had already undergone a procedure to reopen their blocked artery. They used MRI scans to measure heart scarring 6 months later. The goal was to see if this drug, which helps heart cells use energy more efficiently, could limit permanent damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ST-ELEVATION MYOCARDIAL INFARCTION (STEMI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chinese PLA general hospital
Beijing, Haidian, 100853, China
Conditions
Explore the condition pages connected to this study.